Affibody AB
Overview
Affibody AB is a privately held company based in Sweden, specializing in the development of innovative protein-based therapeutics. The company focuses on creating treatment solutions in areas such as oncology and inflammation using its proprietary Affibody® molecule technology.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Affibody AB in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.